Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Mary E. Enama · SciRah

Researcher profile · Semantic Scholar

Mary E. Enama

Share profile

Mary E. Enama — researcher profile on SciRah

h-index: 30
Works: 47
Citations: 6,426

Most-cited papers

Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
R. Seder, Lee-Jah Chang, Mary E. Enama, Kathryn L. Zephir +38 more
2013Science779 citations
Semantic Scholar
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer, M. Sobieszczyk, H. Janes, S. Karuna +26 more
2013New England Journal of Medicine591 citations Open access
Semantic Scholar
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
R. Lynch, E. Boritz, Emily E. Coates, A. Dezure +33 more
2015Science Translational Medicine456 citations Open access
Semantic Scholar
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
A. Ishizuka, K. Lyke, A. Dezure, Andrea A. Berry +52 more
2016Nature Medicine347 citations Open access
Semantic Scholar
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.
Andrew T. Catanzaro, R. Koup, M. Roederer, R. Bailer +15 more
2006Journal of Infectious Diseases335 citations Open access
Semantic Scholar
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV‐1 human monoclonal antibody VRC01 in healthy adults
J. Ledgerwood, Emily E. Coates, G. Yamshchikov, Jamie Saunders +23 more
2015Clinical and Experimental Immunology253 citations Open access
Semantic Scholar
A SARS DNA Vaccine Induces Neutralizing Antibody and Cellular Immune Responses in Healthy Adults in a Phase I Clinical Trial
Julie E. Martin, M. Louder, Lasonji Holman, Ingelise J. Gordon +12 more
2008Vaccine245 citations Open access
Semantic Scholar
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.
Lee-Jah Chang, Kimberly A. Dowd, Floreliz H. Mendoza, Jamie Saunders +15 more
2014The Lancet240 citations
Semantic Scholar
A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial
Julie E. Martin, N. Sullivan, Mary E. Enama, Ingelise J. Gordon +12 more
2006Clinical and Vaccine Immunology238 citations Open access
Semantic Scholar
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
K. Lyke, A. Ishizuka, A. Berry, S. Chakravarty +35 more
2017Proceedings of the National Academy of Sciences of the United States of America236 citations Open access
Semantic Scholar
Chimpanzee Adenovirus Vector Ebola Vaccine
J. Ledgerwood, A. Dezure, Daphne A. Stanley, Emily E. Coates +23 more
2017New England Journal of Medicine222 citations Open access
Semantic Scholar
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.
B. Graham, R. Koup, M. Roederer, R. Bailer +10 more
2006Journal of Infectious Diseases219 citations Open access
Semantic Scholar
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.
J. Ledgerwood, Pamela J. M. Costner, N. Desai, Lasonji Holman +15 more
2010Vaccine218 citations
Semantic Scholar
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
J. Ledgerwood, Chih-Jen Wei, Zong-Hui Hu, Ingelise J. Gordon +12 more
2011Lancet. Infectious Diseases (Print)194 citations Open access
Semantic Scholar
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.
Julie E. Martin, Theodore C. Pierson, Sarah A Hubka, Steven E Rucker +15 more
2007Journal of Infectious Diseases176 citations Open access
Semantic Scholar
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine.
A. Catanzaro, M. Roederer, R. Koup, R. Bailer +9 more
2007Vaccine164 citations
Semantic Scholar
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.
J. Ledgerwood, Theodore C. Pierson, Sarah A Hubka, N. Desai +12 more
2011Journal of Infectious Diseases152 citations Open access
Semantic Scholar
Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
R. Koup, M. Roederer, L. Lamoreaux, J. Fischer +9 more
2010PLoS ONE145 citations Open access
Semantic Scholar
Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect.
J. Ledgerwood, Kathryn L. Zephir, Zong-Hui Hu, Chih-Jen Wei +9 more
2013Journal of Infectious Diseases133 citations Open access
Semantic Scholar
The Safety and Pharmacokinetics of Single-Agent and Combination Therapy with Megestrol Acetate and Dronabinol for the Treatment of HIV Wasting Syndrome
J. Timpone, D. Wright, Ning Li, M. Egorin +3 more
1997AIDS Research and Human Retroviruses132 citations
Semantic Scholar
Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
Uzma N. Sarwar, Pamela J. M. Costner, Mary E. Enama, N. Berkowitz +12 more
2014Journal of Infectious Diseases126 citations Open access
Semantic Scholar
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
H. Kibuuka, N. Berkowitz, M. Millard, Mary E. Enama +20 more
2015The Lancet118 citations Open access
Semantic Scholar
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.
J. Parrino, Lewis H. McCurdy, B. Larkin, Ingelise J. Gordon +9 more
2007Vaccine97 citations Open access
Semantic Scholar
DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
B. Graham, Mary E. Enama, M. Nason, Ingelise J. Gordon +8 more
2013PLoS ONE84 citations Open access
Semantic Scholar
Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects
Jorge A. Tavel, Julie E. Martin, Grace G. Kelly, Mary E. Enama +9 more
2007Journal of Acquired Immune Deficiency Syndromes58 citations Open access
Semantic Scholar
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.
J. Casazza, K. Bowman, S. Adzaku, Emily C. Smith +18 more
2013Journal of Infectious Diseases56 citations Open access
Semantic Scholar
Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
J. Ledgerwood, Zong-Hui Hu, Ingelise J. Gordon, G. Yamshchikov +9 more
2012Clinical and Vaccine Immunology56 citations Open access
Semantic Scholar
Early Bactericidal Activity of Isoniazid in Pulmonary Tuberculosis
Richard Hafner, J. A. Cohn, D. J. Wright, N. E. Dunlap +6 more
199749 citations
Semantic Scholar
Corrigendum: Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1
A. Ishizuka, K. Lyke, A. Dezure, Andrea A. Berry +52 more
2016Nature Medicine48 citations Open access
Semantic Scholar
Randomization to Standard and Concise Informed Consent Forms: Development of Evidence-Based Consent Practices
Mary E. Enama, Zong-Hui Hu, Ingelise J. Gordon, Pamela J. M. Costner +2 more
2012Contemporary Clinical Trials48 citations Open access
Semantic Scholar
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
A. Dezure, Emily E. Coates, Zong-Hui Hu, G. Yamshchikov +16 more
2017npj Vaccines27 citations Open access
Semantic Scholar
Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011)
Mary E. Enama, J. Ledgerwood, L. Novik, M. Nason +8 more
2014PLoS ONE27 citations Open access
Semantic Scholar
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
Katherine V. Houser, G. Yamshchikov, A. Bellamy, Jeanine May +15 more
2018PLoS ONE26 citations Open access
Semantic Scholar
Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults
M. Crank, Ingelise J. Gordon, G. Yamshchikov, S. Sitar +12 more
2015PLoS ONE25 citations Open access
Semantic Scholar
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial
Cristina A Carter, Katherine V. Houser, G. Yamshchikov, A. Bellamy +13 more
2019PLoS ONE18 citations Open access
Semantic Scholar
DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial
J. Ledgerwood, A. Bellamy, R. Belshe, D. Bernstein +12 more
2015PLoS ONE17 citations Open access
Semantic Scholar
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
Myra Happe, Amelia R Hofstetter, Jing Wang, G. Yamshchikov +93 more
2024npj Vaccines15 citations Open access
Semantic Scholar
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)
M. Crank, Eleanor M. P. Wilson, L. Novik, Mary E. Enama +11 more
2016PLoS ONE15 citations Open access
Semantic Scholar
Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.
J. Ledgerwood, A. Dezure, Daphne A. Stanley, L. Novik +23 more
2015New England Journal of Medicine15 citations
Semantic Scholar
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
J. Ledgerwood, Zong-Hui Hu, Pamela J. M. Costner, G. Yamshchikov +13 more
2015Contemporary Clinical Trials13 citations Open access
Semantic Scholar
Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial
Uzma N. Sarwar, L. Novik, Mary E. Enama, Sarah A. Plummer +8 more
2014PLoS ONE7 citations Open access
Semantic Scholar
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial
Maurine D. Miner, A. deCamp, N. Grunenberg, S. De Rosa +35 more
2024EBioMedicine5 citations Open access
Semantic Scholar
VRC 004: Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine in Healthy Uninfected Adults (VRC-HIVDNA009-00-VP)
Julie E. Martin, Mary E. Enama, R. Koup, R. Bailer +4 more
20054 citations Open access
Semantic Scholar
P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen
J. Casazza, K. Bowman, S. Adzaku, D. Ambrozak +7 more
2009Retrovirology1 citations Open access
Semantic Scholar
P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)
J. Ledgerwood, L. Novik, Mary E. Enama, Ingelise J. Gordon +8 more
2009Retrovirology1 citations Open access
Semantic Scholar
Early Innate and Adaptive Immune Responses to Investigational Human Immunodeficiency Virus (HIV)-1 Vaccines (VRC 016 study)
Uzma N. Sarwar, L. Novik, Mary E. Enama, Douglas M. Herrin +4 more
20150 citations Open access
Semantic Scholar
P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults
Mary E. Enama, L. Novik, Lasonji Holman, Ingelise J. Gordon +3 more
2009Retrovirology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Graham×38
Invite
B. Graham — researcher profile on SciRah
R. Bailer×36
Invite
R. Bailer — researcher profile on SciRah
J. Ledgerwood×34
Invite
J. Ledgerwood — researcher profile on SciRah
R. Koup×33
Invite
R. Koup — researcher profile on SciRah

×28

Invite

J. Mascola — researcher profile on SciRah

Ingelise J. Gordon×25

Invite

Ingelise J. Gordon — researcher profile on SciRah

Invite

G. Nabel — researcher profile on SciRah

M. Roederer×21

Invite

M. Roederer — researcher profile on SciRah

Lasonji Holman×16

Invite

Lasonji Holman — researcher profile on SciRah

Invite

L. Novik — researcher profile on SciRah

Zong-Hui Hu×15

Invite

Zong-Hui Hu — researcher profile on SciRah

C. S. Hendel×14

Invite

C. S. Hendel — researcher profile on SciRah